In the Rotterdam study, baseline CRP levels are associated to chronic inflammation preceding lung cancer, even after subtracting a 5-year latent period, as well as a single nucleotide polymorphism of CRP variation of CRP gene (82). This evidence concerns the gene CRP and lung cancer.